Newer Antiepileptic Drugs in the Management of Agitation/Aggression in Patients with Dementia or Developmental Disability
- 1 December 2007
- journal article
- review article
- Published by American Society of Consultant Pharmacists in The Consultant Pharmacist
- Vol. 22 (12) , 1004-1034
Abstract
Objective: To assess the potential role of newer antiepileptic drugs (AEDs) in the management of agitation/aggression in patients with dementia or developmental disability. Data Source: A MEDLINE/PUBMED search (1986-May 2007) was conducted to identify pertinent English language studies of six newer AEDs, as well as carbamazepine and valproate, in the management of agitation/aggression. Study Selection and Data Extraction: All studies evaluating any aspect of management of agitation/aggression, emphasizing those associated with dementia or developmental disability. Data Synthesis: Pharmacotherapy of agitation/aggression in these two patient groups remains an underexplored area. Carbamazepine and valproate have a reasonable, readily available evidence base, and preliminary recommendations regarding their use in these two patient groups. The most published data with newer AEDs involve gabapentin, followed by topiramate. Even so, the literature regarding newer AEDs is modest in volume. Conclusion: Based on current data, gabapentin, oxcarbazepine, and topiramate are qualitatively similar in efficacy to carbamazepine/valproate in the management of agitation/aggression. However, studies-to-date in this field have had, in the main, numerous design flaws. In considering use of newer AEDs, the clinician needs to be aware of potential adverse events that are unique to these agents or infrequently seen with older AEDs (e.g., hyponatremia with oxcarbazepine, and acute myopia and angleclosure glaucoma, urinary tract stones, and cognition difficulties with topiramate). In addition, there is an extensive literature documenting that newer AEDs can precipitate new-onset or worsen existing behavioral disorders, including agitation/aggression.Keywords
This publication has 119 references indexed in Scilit:
- A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2006
- Evidence-Based Interventions for Nursing Home Residents with Dementia-Related Behavioral SymptomsPsychiatric Clinics of North America, 2005
- Adjunctive Divalproex and Hostility Among Patients With Schizophrenia Receiving Olanzapine or RisperidonePsychiatric Services, 2004
- Managing agitation and difficult behavior in dementiaClinics in Geriatric Medicine, 2004
- Sodium valproate in aggressive behaviour in dementia: a twelve‐week open label follow‐up studyInternational Journal of Geriatric Psychiatry, 2004
- Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality DisordersNeuropsychopharmacology, 2003
- Lamotrigine and Borderline Personality DisorderJournal of Child and Adolescent Psychopharmacology, 2002
- Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injuryBrain Injury, 1997
- Efficacy of gabapentin therapy in children with refractory partial seizuresThe Journal of Pediatrics, 1996
- Gabapentin Associated with Aggressive Behavior in Pediatric Patients with SeizuresEpilepsia, 1996